Location: Seoul, Korea, Republic of
CIK: 0001710065 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 8, 2026
Total Value: $30.52M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 223,486 | $25.66M | 84.1% | $16.72 | +326.5% | COMMON STOCK | 03940C100 |
| KYMR | KYMERA THERAPEUTICS INC | 19,648 | $1.636M | 5.4% | $48.78 | +59.1% | COM | 501575104 |
| SEER | SEER INC | 816,375 | $1.543M | 5.1% | $63.62 | -97.0% | COM CL A | 81578P106 |
| RLYB | RALLYBIO CORP | 94,334 | $846K | 2.8% | $5.22 | 0.0% | COM | 75120L209 |
| — | SUTRO BIOPHARMA INC | 17,500 | $436K | 1.4% | $21.71 | — | COM SHS | 869367102 |
| XLO | XILIO THERAPEUTICS INC | 47,695 | $401K | 1.3% | $8.41 | — | COM | 98422T209 |